N-formyl hydroxylamine containing dipeptides:: Generation of a new class of vasopeptidase inhibitors

被引:30
作者
Robl, JA [1 ]
Simpkins, LM [1 ]
Asaad, MM [1 ]
机构
[1] Bristol Myers Squibb Pharmaceut Res Inst, Princeton, NJ 08543 USA
关键词
D O I
10.1016/S0960-894X(99)00671-X
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Four primary zinc-binding pharmacophores (thiols, carboxylates, phosphorus acids, and hydroxamates) have been utilized in generating inhibitors of zinc metalloproteases such as ACE, NEP, the MMPs, and ECE. Although compounds which inhibit the activity of both ACE and NEP (vasopeptidase inhibitors, VPIs) have been reported which incorporate a thiol, carboxylate, or phosphorus acid pharmacophore, the generation of hydroxamate based vasopeptidase inhibitors has remained elusive. Herein we report the first potent vasopeptidase inhibitors which were generated from the incorporation of conformationally restricted dipeptide mimetics to an N-formyl hydroxylamine zinc-binding group. Compounds such as 13c and 13d are among the most potent in this series, exhibiting in vitro activity comparable to other classes of inhibitors. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:257 / 260
页数:4
相关论文
共 22 条
[1]  
BHAGWAT S, 1997, 14 INT S MED CHEM P, P15
[2]  
BREALY CJ, 1995, EUR M HYP 7 MIL
[3]  
DeLombaert S, 1996, CURR PHARM DESIGN, V2, P443
[4]   DUAL INHIBITION OF NEUTRAL ENDOPEPTIDASE AND ANGIOTENSIN-CONVERTING ENZYME BY N-PHOSPHONOMETHYL AND N-CARBOXYALKYL DIPEPTIDES [J].
DELOMBAERT, S ;
TAN, J ;
STAMFORD, LJ ;
SAKANE, Y ;
BERRY, C ;
GHAI, RD .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (22) :2715-2720
[5]   Recent advances in the development of dual angiotensin-converting enzyme and neutral endopeptidase inhibitors [J].
Fink, CA .
EXPERT OPINION ON THERAPEUTIC PATENTS, 1996, 6 (11) :1147-1164
[6]   APPLICATION OF A CONFORMATIONALLY RESTRICTED PHE-LEU DIPEPTIDE MIMETIC TO THE DESIGN OF A COMBINED INHIBITOR OF ANGIOTENSIN I-CONVERTING ENZYME AND NEUTRAL ENDOPEPTIDASE-24.11 [J].
FLYNN, GA ;
BEIGHT, DW ;
MEHDI, S ;
KOEHL, JR ;
GIROUX, EL ;
FRENCH, JF ;
HAKE, PW ;
DAGE, RC .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (16) :2420-2423
[7]  
Flynn Gary A., 1995, P3099
[8]   NEW BIDENTATES AS FULL INHIBITORS OF ENKEPHALIN-DEGRADING ENZYMES - SYNTHESIS AND ANALGESIC PROPERTIES [J].
FOURNIEZALUSKI, MC ;
COULAUD, A ;
BOUBOUTOU, R ;
CHAILLET, P ;
DEVIN, J ;
WAKSMAN, G ;
COSTENTIN, J ;
ROQUES, BP .
JOURNAL OF MEDICINAL CHEMISTRY, 1985, 28 (09) :1158-1169
[9]  
Graul A., 1999, Drugs of the Future, V24, P269, DOI 10.1358/dof.1999.024.03.489142
[10]  
HANDA BK, 1987, Patent No. 236872